Socioeconomic position and clinical outcomes in patients with myelodysplastic syndromes: A population‐based cohort study

• Published in: Hematological oncology Vol. 40; no. 5; pp. 1056 - 1066
• Main Authors: Lauritsen, Tine Bichel, Østgård, Lene Sofie Granfeldt, Grønbæk, Kirsten, Dalton, Susanne Oksbjerg, Nørgaard, Jan Maxwell
• Format: Journal Article
• Language: English
• Published: England Wiley Subscription Services, Inc 01-12-2022; John Wiley and Sons Inc
• Subjects: Acute myeloid leukemia; Clinical outcomes; Cohabitation; Cohort analysis; Cohort Studies; Confidence intervals; Diagnosis; Disorders; Education; Health services; Humans; Income; Leukemia; Myelodysplastic syndrome; Myelodysplastic syndromes; Myelodysplastic Syndromes - therapy; Original; outcomes; Patients; Population studies; Population-based studies; prognosis; Regression analysis; Risk; Socioeconomic factors; socioeconomic position; Socioeconomics; Statistical analysis; Stem cell transplantation; Stem cells; Transfusion; Transplantation; socioeconomic position; outcomes; prognosis; myelodysplastic syndromes
• ISSN: 0278-0232; 1099-1069
• DOI: 10.1002/hon.3068

Low socioeconomic position (SEP) may be associated with adverse outcomes in patients with myelodysplastic syndromes (MDS) inherent to for example, delayed diagnosis or reduced treatment intensity, but firm evidence is limited. In this study, we examined the association between SEP and clinical outcomes. We conducted a population‐based cohort study (2010–2018) of 2233 Danish patients with MDS. SEP measures included individual‐level information on education, cohabitation status and income retrieved from Statistics Denmark. Associations between SEP measures and disease severity at diagnosis were examined using binomial regression analysis. Using time‐to‐event analysis, we examined the association between SEP measures and treatment with allogeneic stem cell transplantation (allo‐HSCT), risk of progression to acute myeloid leukemia (AML), and death. Estimates were adjusted for covariates selected based on direct acyclic graphs and reported with 95% confidence intervals. Patients with a short education were more likely to be transfusion‐dependent at diagnosis (RR = 1.25, 95% CI: 1.04–1.45) and more likely to be diagnosed with higher risk MDS according to the International Prognostic Scoring System (RR = 1.29, 95% CI: 1.03–1.62), than patients with a long education. We found no clear association between SEP and risk of progression to AML. In adjusted models, the 1‐year risk of dying was higher in patients with short versus long education (RR = 1.34, 95% CI: 1.08–1.65), in patients with low versus high income (RR = 1.42, 95% CI: 1.14–1.77), and among patients who lived alone compared to those who lived with a partner (RR = 1.15, 0.98–1.35). These associations persisted after 3 years and 5 years of follow‐up. Notably, patients with a short education had a markedly lower rate of undergoing treatment with allo‐HSCT compared to patients with a long education (HR = 0.51, 95% CI: 0.31–0.84). In conclusion, low SEP and especially short education, were poor prognostic factors for adverse clinical outcomes among patients with MDS.